Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia

Despite having several characteristics of naı̈ve B cells, chronic lymphocytic leukemia (CLL) cells have been shown in some cases to have somatically mutated Ig variable region genes, indicating that the cell of origin has passed through the germinal center. A previous study of patients with CLL found an association between lack of somatic mutation and trisomy 12 and, therefore, possibly with a less favorable prognosis. We have sequenced the Ig VH genes of the tumor cells of 84 patients with CLL and correlated our findings with clinical features. A total of 38 cases (45.2%) showed H 98% sequence homology with the nearest germline VH gene; 46 cases (54.8%) showed G2% somatic mutation. Unmutated VH genes were significantly associated with V1-69 and D3-3 usage, with atypical morphology; isolated trisomy 12, advanced stage and progressive disease. Survival was significantly worse for patients with unmutated VH genes irrespective of stage. Median survival for stage A patients with unmutated VH genes was 95 months compared with 293 months for patients whose tumors had mutated VH genes (P 5 .0008). The simplest explanation is that CLL comprises 2 different diseases with different clinical courses. One, arising from a memory B cell, has a benign course, the other, arising from a naı̈ve B cell, is more malignant. r 1999 by The American Society of Hematology.

[1]  D. Catovsky,et al.  Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). , 1996, Leukemia.

[2]  S. Emerson,et al.  Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. , 1986, Journal of immunology.

[3]  Pojen P. Chen,et al.  Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Oscier,et al.  Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myeloma. , 1994, Leukemia.

[5]  J. Binet,et al.  A clinical staging system for chronic lymphocytic leukemia. Prognostic significance , 1977, Cancer.

[6]  T. Hamblin,et al.  Identification of normal B‐cell counterparts of neoplastic cells which secrete cold agglutinins of anti‐I and anti‐i specificity , 1989, British journal of haematology.

[7]  L. Rassenti,et al.  Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. , 1997, Journal of immunology.

[8]  R. Levy,et al.  Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. , 1992, Molecular immunology.

[9]  I. Tomlinson,et al.  The human immunoglobulin VH repertoire. , 1995, Immunology today.

[10]  R. Brezinschek,et al.  Similar characteristics of the CDR3 of VH1‐69/DP‐10 rearrangements in normal human peripheral blood and chronic lymphocytic leukaemia B cells , 1998, British journal of haematology.

[11]  M. Melamed,et al.  Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. , 1980, Blood.

[12]  E L Sonnhammer,et al.  Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. , 1997, Journal of molecular biology.

[13]  R. Hawkins,et al.  Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes , 1994, British journal of haematology.

[14]  P. Casali,et al.  The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. , 1994, Immunology today.

[15]  D. Catovsky,et al.  The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. , 1994, Leukemia.

[16]  C. Milstein,et al.  Mutation Drift and Repertoire Shift in the Maturation of the Immune Response , 1987, Immunological reviews.

[17]  N. Chiorazzi,et al.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.

[18]  D. Oscier,et al.  Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. , 1997, Blood.

[19]  D. Mason,et al.  Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. , 1990, The American journal of pathology.

[20]  T. Logtenberg,et al.  Expression of members of the immunoglobulin VH3 gene families is not restricted at the level of individual genes in human chronic lymphocytic leukemia. , 1992, International immunology.

[21]  G. Winter,et al.  Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines. , 1994, Blood.

[22]  M. Dyer,et al.  BCL2 translocations in leukemias of mature B cells. , 1994, Blood.

[23]  T. Kipps,et al.  Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number. , 1996, The Journal of clinical investigation.

[24]  L. Rassenti,et al.  Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. , 1998, The Journal of clinical investigation.

[25]  J. Norton,et al.  Preferential rearrangement of developmentally regulated immunoglobulin VH1 genes in human B-lineage leukaemias. , 1991, Leukemia.

[26]  D. Catovsky,et al.  The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. , 1994, Blood.

[27]  H. Zola,et al.  Memory B lymphocytes in human tonsil do not express surface IgD. , 1995, Journal of immunology.

[28]  E. Sasso,et al.  A fetally expressed immunoglobulin VH1 gene belongs to a complex set of alleles. , 1993, The Journal of clinical investigation.

[29]  S. Knuutila,et al.  Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. , 1990, The New England journal of medicine.

[30]  D. Catovsky,et al.  Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients , 1996, British journal of haematology.

[31]  J. Riley,et al.  Structure and physical map of 64 variable segments in the 3′ 0.8–megabase region of the human immunoglobulin heavy–chain locus , 1993, Nature Genetics.

[32]  G. Dighiero,et al.  The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. , 1994, Immunology today.

[33]  F. Caligaris‐cappio.  B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. , 1996, Blood.